|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.86 USD | +0.32% |
|
+3.83% | +1.95% |
| 07:55pm | Wedbush Raises Price Target on Sarepta Therapeutics to $34 From $32, Keeps Outperform Rating | MT |
| 13/01 | Sarepta reconfirms yearly sales floor for Elevidys of $500.0 mln | RE |
Quotes 5-day view: Sarepta Therapeutics, Inc.
Delayed Quote Nasdaq| 16/01/2026 | 20/01/2026 | 21/01/2026 | 22/01/2026 | 23/01/2026 | |
|---|---|---|---|---|---|
| Last | 21.13 $ | 21.04 $ | 21.37 $ | 21.79 $ | 21.94 $ |
| Volume | 22,69,513 | 17,40,252 | 22,81,437 | 20,33,328 | 12,05,073 |
| Change | -0.84% | -0.43% | +1.57% | +1.97% | +0.32% |
| Opening | 21.25 $ | 20.53 $ | 20.97 $ | 21.37 $ | 21.89 $ |
| High | 21.51 $ | 21.22 $ | 21.88 $ | 21.81 $ | 22.60 $ |
| Low | 20.81 $ | 20.10 $ | 20.90 $ | 21.06 $ | 21.60 $ |
Performance
| 1 day | +0.18% | ||
| 1 week | +3.83% | ||
| Current month | +1.95% | ||
| 1 month | -0.27% | ||
| 3 months | +0.23% | ||
| 6 months | +64.71% | ||
| Current year | +1.95% | ||
| 1 year | -81.58% | ||
| 3 years | -82.90% | ||
| 5 years | -77.17% | ||
| 10 years | +81.62% |
Volumes
marketsDaily volume
12,05,073
Estimated daily volume
23,14,975
Avg. Volume 20 sessions
30,29,802
Daily volume ratio
0.76
Avg. Volume 20 sessions USD
6,62,31,471.72
Record volume 1
13,12,99,958
Record volume 2
7,84,37,714
Record volume 3
6,75,70,429
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Capitalization (USD)
2,28,33,12,804
Net sales (USD)
1,90,19,79,000
Number of employees
1,372
Sales / Employee (USD)
13,86,282
Free-Float
95.63 %
Free-Float capitalization (USD)
1,99,04,35,027
Average Daily Capital Traded
2.9%
Indicators
Moving average 5 days
21.33
Moving average 20 days
21.9
Moving average 50 days
20.69
Moving average 100 days
20.59
Price spread / (MMA5)
-2.41%
Price spread / (MMA20)
+0.16%
Price spread / (MMA50)
-5.35%
Price spread / (MMA100)
-5.83%
STIM
RSI 9 days
46.75
RSI 14 days
48.63
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | +3.83% | -81.58% | -82.90% | 228.33Cr | ||
| +3.53% | +7.56% | -46.06% | -43.49% | 225.35Cr | ||
| +2.92% | +1.73% | +9.07% | -41.22% | 36Cr | ||
| +2.16% | +4.72% | - | - | 7.59Cr | ||
| Average | +2.23% | +2.38% | -39.53% | -55.87% | 124.21Cr | |
| Weighted average by Cap. | +1.98% | +1.17% | -58.63% | -61.72% |
Historical Quotes: Sarepta Therapeutics, Inc.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
daa722629ebeca9f.T8KE8NuT2fLxkcKtDUxvOebmM-enHlI_bRKjadYNGrM.ffrtv-LWjrOfoIjMUiMWTKGTY5LwbgdlKXXXGqBoX_E_rMapmdK0s8L88g
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:22:46 pm | 21.94 | 100 | 7,98,642 |
| 11:22:40 pm | 21.92 | 100 | 7,98,542 |
| 11:22:35 pm | 21.94 | 100 | 7,98,442 |
| 11:22:14 pm | 21.94 | 100 | 7,98,342 |
| 11:22:13 pm | 21.94 | 100 | 7,98,242 |
| 11:22:13 pm | 21.94 | 110 | 7,98,142 |
| 11:22:06 pm | 21.92 | 100 | 7,98,032 |
| 11:21:23 pm | 21.94 | 800 | 7,97,932 |
| 11:21:23 pm | 21.94 | 100 | 7,97,132 |
| 11:21:13 pm | 21.92 | 100 | 7,97,032 |
Course Extremes
| 1 week | 20.1 | 22.6 | |
| 1 month | 20.1 | 24.12 | |
| Current year | 20.1 | 24.12 | |
| 1 year | 10.42 | 120.05 | |
| 3 years | 10.42 | 173.25 | |
| 5 years | 10.42 | 173.25 | |
| 10 years | 8 | 181.83 |
Monthly variations
Annual variations
| 2026 | +1.25% | ||
| 2025 | -82.30% | ||
| 2024 | +26.09% | ||
| 2023 | -25.58% | ||
| 2022 | +43.90% | ||
| 2021 | -47.18% | ||
| 2020 | +32.12% | ||
| 2019 | +18.24% | ||
| 2018 | +96.14% | ||
| 2017 | +102.84% | ||
| 2016 | -28.90% | ||
| 2015 | +166.62% | ||
| 2014 | -28.96% | ||
| 2013 | -21.05% | ||
| 2012 | +477.18% | ||
| 2011 | -64.86% | ||
| 2010 | +45.21% | ||
| 2009 | +121.88% | ||
| 2008 | -53.33% | ||
| 2007 | -55.66% | ||
| 2006 | -7.83% | ||
| 2005 | +46.81% | ||
| 2004 | -42.26% | ||
| 2003 | -18.60% | ||
| 2002 | -54.21% | ||
| 2001 | +129.89% | ||
| 2000 | -12.64% | ||
| 1999 | +35.94% | ||
| 1998 | -41.28% | ||
| 1997 | +4.81% |
- Stock Market
- Equities
- SRPT Stock
- Quotes Sarepta Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















